The Improved Experience You’ve Been Waiting For!
Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach.
Explore Now
Based on the Bayer Cropscience Limited stock forecast from 0 analysts, the average analyst target price for Bayer Cropscience Limited is not available over the next 12 months. Bayer Cropscience Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bayer Cropscience Limited is Slightly Bullish , which is based on 8 positive signals and 4 negative signals. At the last closing, Bayer Cropscience Limited’s stock price was INR 6,335.05. Bayer Cropscience Limited’s stock price has changed by +0.73% over the past week, -6.46% over the past month and +19.64% over the last year.
No recent analyst target price found for Bayer Cropscience Limited
No recent average analyst rating found for Bayer Cropscience Limited
Company Overview Bayer Cropscience Limited
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines primarily in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance imaging devices. In addition, the company offers consumer health products that are used as a daily health solution to treat minor illnesses, as well as sells and distributes hybrid seeds, such as corn and paddy. Further, it provides digital farming products comprising FarmRise and other digital applications, such as drones for spray services, etc., as well as provides various technologies, such as remote sensing, IoT sensors, GPS, artificial intelligence, and data analytics to monitor and manage crop growth, soil quality, weather patterns, and other factors. The company also exports its products. Bayer CropScience Limited was founded in 1863 and is based in Thane, India. Address: Bayer House, Thane, India, 400 607 Read Less
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines primarily in the therapeutic area...Read More
Frequently Asked Questions About Bayer Cropscience Limited (BAYERCROP:NSE) Stock
Stock Target Advisor's fundamental analysis for Bayer Cropscience Limited's stock is Slightly Bullish .
BAYERCROP:NSE stock's dividend yield is 2.21%.
Our analysis grades BAYERCROP:NSE stock's dividend yield at A+. This means that BAYERCROP:NSE stock's dividend yield is above 100% of the stocks in the Agricultural Inputs sector in the NSE exchange.
Based on this BAYERCROP:NSE may be a good dividend stock for its sector.
Unfortunately we do not have enough data on BAYERCROP:NSE's stock to indicate what its average analyst target is.
BAYERCROP:NSE stock's Price/Earning ratio is 42.74.
Our analysis grades BAYERCROP:NSE stock's Price / Earning ratio at F. This means that BAYERCROP:NSE stock's Price/Earning ratio is above 60% of the stocks in the Agricultural Inputs sector in the NSE exchange.
Based on this BAYERCROP:NSE may be a overvalued for its sector.
The last closing price of BAYERCROP:NSE's stock was INR 6,335.05.
The most recent market capitalization for BAYERCROP:NSE is INR 289.65B.
Unfortunately we do not have enough analyst data on BAYERCROP:NSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Bayer Cropscience Limited's stock.
As per our most recent records Bayer Cropscience Limited has 1,317 Employees.
Bayer Cropscience Limited's registered address is Bayer House, Thane, India, 400 607.
You can get more information about it from Bayer Cropscience Limited's website at https://www.bayer.in.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Bayer Cropscience Limited (BAYERCROP:NSE) Stock
Stock Target Advisor's fundamental analysis for Bayer Cropscience Limited's stock is Slightly Bullish .
BAYERCROP:NSE stock's dividend yield is 2.21%.
Our analysis grades BAYERCROP:NSE stock's dividend yield at A+. This means that BAYERCROP:NSE stock's dividend yield is above 100% of the stocks in the Agricultural Inputs sector in the NSE exchange.
Based on this BAYERCROP:NSE may be a good dividend stock for its sector.
Unfortunately we do not have enough data on BAYERCROP:NSE's stock to indicate what its average analyst target is.
BAYERCROP:NSE stock's Price/Earning ratio is 42.74.
Our analysis grades BAYERCROP:NSE stock's Price / Earning ratio at F. This means that BAYERCROP:NSE stock's Price/Earning ratio is above 60% of the stocks in the Agricultural Inputs sector in the NSE exchange.
Based on this BAYERCROP:NSE may be a overvalued for its sector.
The last closing price of BAYERCROP:NSE's stock was INR 6,335.05.
The most recent market capitalization for BAYERCROP:NSE is INR 289.65B.
Unfortunately we do not have enough analyst data on BAYERCROP:NSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Bayer Cropscience Limited's stock.
As per our most recent records Bayer Cropscience Limited has 1,317 Employees.
Bayer Cropscience Limited's registered address is Bayer House, Thane, India, 400 607.
You can get more information about it from Bayer Cropscience Limited's website at https://www.bayer.in.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BAYERCROP:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
